Venmax Drugs and Pharmaceuticals Limited (BOM:531015)
India flag India · Delayed Price · Currency is INR
23.85
+0.74 (3.20%)
At close: Mar 9, 2026

BOM:531015 Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020 - 2016
Net Income
8.72-0.110.652.2618.46-1.62
Upgrade
Depreciation & Amortization
0.050.060.070.080.090.1
Upgrade
Asset Writedown & Restructuring Costs
0.190.19----
Upgrade
Other Operating Activities
-0.04-0.04-0.01000.01
Upgrade
Change in Accounts Receivable
-47.29-9.530.36--00.02
Upgrade
Change in Inventory
-15.72-0.58---2.16
Upgrade
Change in Accounts Payable
58.685.25-2.25-1.420.060.63
Upgrade
Change in Other Net Operating Assets
-120.09-18.171.2-0.950.441.35
Upgrade
Operating Cash Flow
-115.49-22.90.02-0.0319.052.64
Upgrade
Operating Cash Flow Growth
----621.97%-
Upgrade
Short-Term Debt Issued
---0.03--
Upgrade
Total Debt Issued
32.76--0.03--
Upgrade
Short-Term Debt Repaid
--3.03---19.8-1.9
Upgrade
Total Debt Repaid
-3.03-3.03---19.8-1.9
Upgrade
Net Debt Issued (Repaid)
29.73-3.03-0.03-19.8-1.9
Upgrade
Other Financing Activities
100.0150.73----
Upgrade
Financing Cash Flow
129.7447.7-0.03-19.8-1.9
Upgrade
Miscellaneous Cash Flow Adjustments
-----0-
Upgrade
Net Cash Flow
14.2524.80.02--0.750.74
Upgrade
Free Cash Flow
-115.49-22.90.02-0.0319.052.64
Upgrade
Free Cash Flow Growth
----621.97%-
Upgrade
Free Cash Flow Margin
-261.66%-283.69%---157.18%
Upgrade
Free Cash Flow Per Share
-18.18-4.370.00-0.013.640.50
Upgrade
Cash Income Tax Paid
0.32-0.23---
Upgrade
Levered Free Cash Flow
-125.44-29.5-1.32-3.5-0.273.25
Upgrade
Unlevered Free Cash Flow
-125.44-29.5-1.32-3.5-0.273.25
Upgrade
Change in Working Capital
-124.42-23.01-0.69-2.370.54.15
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.